Omega Advisors’s Dermira, Inc. DERM Stock Holding History

Omega Advisors’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-69,700	Closed	-$2.38M	–	97
2017 Q1	$2.38M	Buy	+69,700	New	+$2.25M	0.1%	70

Other funds holding DERM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Omega Advisors's DERM Position: Q2 2017 in Review

Omega Advisors sold out of Dermira, Inc. (DERM) in Q2 2017, closing a stake of 69,700 shares — an estimated $2.38M sold.

Omega Advisors first reported a position in DERM in Q1 2017 and held it in 1 quarter. The position peaked at $2.38M in Q1 2017. 121 funds tracked by Wall St. Rank hold DERM as of Q2 2017.

Omega Advisors reported no remaining Dermira, Inc. position as of Q2 2017 after selling out during the quarter.
Omega Advisors sold 69,700 Dermira, Inc. shares in Q2 2017, an estimated $2.38M.
Omega Advisors first reported a position in Dermira, Inc. in Q1 2017 and held it in 1 quarter.
Omega Advisors's Dermira, Inc. position peaked at $2.38M in Q1 2017.
121 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2017.

Based on Omega Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.